Emerald hosting conference call today, December 1st, at 10:30 am ET Vancouver, British Columbia–(Newsfile Corp. – December 1, 2020) – Emerald Health Therapeutics, Inc. (TSXV: EMH)...
Emerald to report Q3 financial results on November 30th and host conference call on December 1st at 10:30 am ET Vancouver, British Columbia–(Newsfile Corp. – November...
Vancouver, British Columbia–(Newsfile Corp. – November 2, 2020) – Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the “Company”) has completed the previously disclosed sale of...
Vancouver, British Columbia–(Newsfile Corp. – November 2, 2020) – Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the “Company”) has completed the previously disclosed sale...
Vancouver, British Columbia–(Newsfile Corp. – October 29, 2020) – Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the “Company”) is pleased to announce that its shareholders...
Combination of appealing natural flavourings and terpenes offers unique consumer experience Emerald also launches new SYNC CBD nanoemulsion-based Fast Action Spray in BC and Saskatchewan Vancouver,...
Processing license permits Richmond site to process consumer products and vertically integrate into potential product segments Vancouver, British Columbia–(Newsfile Corp. – October 13, 2020) – Emerald...
Vancouver, British Columbia–(Newsfile Corp. – September 16, 2020) – Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the “Company”) has closed its previously announced shares for...
Vancouver, British Columbia–(Newsfile Corp. – September 10, 2020) – Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (“Emerald”) and STENOCARE A/S today announced that they have...
Vancouver, British Columbia–(Newsfile Corp. – September 8, 2020) – Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the “Company”) is pleased to announce that it has...